4//SEC Filing
ADELMAN BURT A 4
Accession 0000950170-24-078784
CIK 0001840574other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 7:45 AM ET
Size
5.7 KB
Accession
0000950170-24-078784
Insider Transaction Report
Form 4
ADELMAN BURT A
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-26+136,139→ 136,139 totalExercise: $5.02Exp: 2034-06-25→ Common Stock (136,139 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date (the "Vesting Commencement Date") of the options is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or immediately prior to the first annual meeting of stockholders occurring after the grant date, in each case subject to the Reporting Person's continued service as a director.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001226283
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 7:45 AM ET
- Size
- 5.7 KB